Adam Foley-Comer

Adam Foley-Comer is an experienced medical executive currently serving as Chief Medical Officer at PROTA THERAPEUTICS PTY LTD since September 2024 and at KAHR-medical Ltd. since November 2017. Prior roles include Senior Medical Director at Quark Pharmaceuticals Inc., where responsibilities encompassed early clinical development activities for siRNA projects, and Medical Director at Wize Pharma Ltd., focusing on ophthalmology strategy and Phase 2 study implementations. Adam also held the position of Medical Director at BioLineRx, providing leadership and medical guidance across clinical teams. Educational qualifications include an MSc in Surgical Science from UCL and a FRCS (Eng) in Surgery from the Royal College of Surgeons.